HIGHLIGHTS
- who: Shivani Khattar and collaborators from the Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, Department of Dental Technology, College of Applied Medical Sciences, King Khalid University have published the research: Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential, in the Journal: Pharmaceuticals 2022, 15, 957. of /2022/
SUMMARY
Resveratrol (3, 40, 5-trihydroxystilbene) is a stilbenoid class of compound and works as phytoalexin (i.e., a substance that is produced by plant tissues in response to contact with a parasite and specifically inhibits the growth . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.